Xenovulene A
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Category | Enzyme inhibitors |
Catalog number | BBF-02979 |
CAS | |
Molecular Weight | 358.47 |
Molecular Formula | C22H30O4 |
Online Inquiry
Capabilities & Facilities
Fermentation Lab
4 R&D and scale-up labs
2 Preparative purification labs
Fermentation Plant
Semi pilot, pilot and industrial plant 4 Manufacturing sites 7 Production lines at pilot scale 100+ Reactors of 30-4000 L; 170+ reactors of 20 KL-30 KL; 24+ reactors of >100 KL 2 Hydrogenation reactors (200 L, 4Mpa and 1000L, 4Mpa)
Product Description
It is produced by the strain of Acremonium strcturn. It has the effect of inhibiting the binding of Flunitrazepam to γ-aminobutyric acid-benzodiazapine with IC50 of 40 nmol/L.
- Specification
- Properties
- Reference Reading
- Price Product List
Synonyms | (2aR,5aR,11E,14aS,14bS,14cS)-4-Hydroxy-5a,9,9,12-tetramethyl-2a,5a,6,9,10,13,14,14a,14b,14c-decahydro-1,5-dioxacyclopenta[cd]cycloundeca[f]inden-3(2H)-one |
IUPAC Name | (1S,2S,5E,9E,12R,17R,20S)-15-hydroxy-5,8,8,12-tetramethyl-13,19-dioxatetracyclo[12.5.1.02,12.017,20]icosa-5,9,14-trien-16-one |
Canonical SMILES | CC1=CCC(C=CCC2(C(CC1)C3C4C(CO3)C(=O)C(=C4O2)O)C)(C)C |
InChI | InChI=1S/C22H30O4/c1-13-6-7-15-19-16-14(12-25-19)17(23)18(24)20(16)26-22(15,4)10-5-9-21(2,3)11-8-13/h5,8-9,14-16,19,24H,6-7,10-12H2,1-4H3/b9-5+,13-8+/t14-,15-,16-,19-,22+/m0/s1 |
InChI Key | WDFUVZRTUNQXHC-KVPIFFDFSA-N |
Appearance | White Powder |
Boiling Point | 487.1±45.0°C at 760 mmHg |
Density | 1.2±0.1 g/cm3 |
Solubility | Soluble in Methanol |
BBF-05843 | Bacitracin | Inquiry |
BBF-03427 | Tubercidin | Inquiry |
BBF-03516 | (±)-Naringenin | Inquiry |
BBF-02627 | Rapamycin | Inquiry |
BBF-02577 | Pneumocandin C0 | Inquiry |
BBF-00586 | Brefeldin A | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
